Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective binding in biological systems, making it valuable in medicinal chemistry. The compound is also employed in the preparation of fluorinated analogs to improve metabolic stability and bioavailability in drug candidates. Commonly utilized in research settings for structure-activity relationship (SAR) studies due to the presence of fluorine atoms and the strained cyclobutane ring, which influence potency and selectivity.